Camber Pharmaceuticals Launches Generic Concerta®
Piscataway, NJ, September 5, 2019– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate ER Tablets to our growing portfolio of products.
Methylphenidate ER tablets are the generic version of Concerta®. Methylphenidate is used to treat attention-deficit hyperactivity disorder (ADHD). Methylphenidate ER tablets are available in a 18, 27, 36 and 54 mg- 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






